Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Job F. Eijsink
Department of clinical pharmacy, Isala klinieken, Zwolle, The Netherlands, Netherlands
Poster(s):
(BSPOT43) Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: a nationwide retrospective cohort study with a non-inferiority primary objective.
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
